Hepatic temporal gene expression profiling in Helicobacter hepaticus-infected A/JCr mice

Toxicologic Pathology

Volumn 32, Issue 6, 2004, Pages 678-693

  Boutin, Samuel R ^a   Rogers, Arlin B ^a   Shen, Zeli ^a   Fry, Rebecca C ^a   Love, Jennifer A ^b   Nambiar, Prashant R ^a   Suerbaum, Sebastian ^c   Fox, James G ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Carcinoma, hepatocellular; Helicobacter; Hepatitis, chronic; Inbred; Mice; Microarray

Indexed keywords

FATTY ACID; PEROXISOME PROLIFERATOR; STEROID; TUMOR MARKER;

ANIMAL MODEL; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HELICOBACTER HEPATICUS; LIVER CELL CARCINOMA; LIVER CELL DAMAGE; LIVER DISEASE; MALE; MOUSE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; STEROID METABOLISM; UPREGULATION;

AGING; ANIMALS; CELL PROLIFERATION; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HELICOBACTER HEPATICUS; HELICOBACTER INFECTIONS; INFLAMMATION; LIVER; MICE; MICE, INBRED A; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

ANIMALIA; HELICOBACTER; HELICOBACTER HEPATICUS; NEGIBACTERIA;

EID: 8544279630     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230490524058     Document Type: Article

References (99)

1. Al-azzeh, E., Dittrich, O., Vervoorts, J., Blin, N., Gott, P., and Luscher, B. (2002). Gastroprotective peptide trefoil factor family 2 gene is activated by upstream stimulating factor but not by c-Myc in gastrointestinal cancer cells. Gut 51, 685-90.
2. Avenaud, P., Marais, A., Monteiro, L., Le Bail, B., Bioulac Sage, P., Balabaud, C., and Megraud, F. (2000). Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 89, 1431-9.
3. Bai, F., Nakanishi, Y., Takayama, K., Pei, X. H., Inoue, K., Harada, T., Izumi, M., and Hara, N. (2003). Codon 64 of K-ras gene mutation pattern in hepatocellular carcinomas induced by bleomycin and 1-nitropyrene in A/J mice. Teratog Carcinog Mutagen Suppl 1, 161-70.
4. Bartsch, S., and Tschesche, H. (1995). Cloning and expression of human neutrophil lipocalin cDNA derived from bone marrow and ovarian cancer cells. FEBS Lett 357, 255-9.
5. Bautista, A. P., and Spitzer, J. J. (1990). Superoxide anion generation by in situ perfused rat liver: effect of in vivo endotoxin. Am J Physiol 259, G907-12.
6. Bondy, S. C., and Naderi, S. (1994). Contribution of hepatic cytochrome P450 systems to the generation of reactive oxygen species. Biochem Pharmacol 48, 155-9.
7. Brannan, C. I., and Bartolomei, M. S. (1999). Mechanisms of genomic imprinting. Curr Opin Genet Dev 9, 164-70.
8. Brannan, C. I., Dees, E. C., Ingram, R. S., and Tilghman, S. M. (1990). The product of the H19 gene may function as an RNA. Mol Cell Biol 10, 28-36.
9. Bratt, T. (2000). Lipocalins and cancer. Biochim Biophys Acta 1482, 318-26.
10. Cao, S. X., Dhahbi, J. M., Mote, P. L., and Spindler, S. R. (2001). Genomic profiling of short- and long-term caloric restriction effects in the liver of aging mice. Proc Natl Acad Sci USA 98, 10630-5.
11. Cavaggioni, A., and Mucignat-Caretta, C. (2000). Major urinary proteins, alpha(2U)-globulins and aphrodisin. Biochim Biophys Acta 1482, 218-28.
12. Chan, I. T., Kutok, J. L., Williams, I. R., Cohen, S., Kelly, L., Shigematsu, H., Johnson, L., Akashi, K., Tuveson, D. A., Jacks, T., and Gilliland, D. G. (2004). Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J Clin Invest 113, 528-38.
13. Chomarat, P., Sipowicz, M. A., Diwan, B. A., Fornwald, L. W., Awasthi, Y. C., Anver, M. R., Rice, J. M., Anderson, L. M., and Wild, C. P. (1997). Distinct time courses of increase in cytochromes P450 1A2, 2A5 and glutathione S-transferases during the progressive hepatitis associated with Helicobacter hepaticus. Carcinogenesis 18, 2179-90.
14. Devireddy, L. R., Teodoro, J. G., Richard, F. A., and Green, M. R. (2001). Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 293, 829-34.
15. Diwan, B. A., Ward, J. M., Ramljak, D., and Anderson, L. M. (1997). Promotion by Helicobacter hepaticus-induced hepatitis of hepatic rumors initiated by N-nitrosodimethylamine in male A/JCr mice. Toxicol Pathol 25, 597-605.
16. Eaton, J. W., Brandt, P., Mahoney, J. R., and Lee, J. T., Jr. (1982). Haptoglobin: a natural bacteriostat. Science 215, 691-3.
17. Echtermeyer, F., Streit, M., Wilcox-Adelman, S., Saoncella, S., Denhez, F., Detmar, M., and Goetinck, P. (2001). Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest 107, R9-R14.
18. Edwards, J., Krishna, N. S., Witton, C. J., and Bartlett, J. M. (2003). Gene amplifications associated with the development of hormone-resistant prostate cancer. Clin Cancer Res 9, 5271-81.
19. Erdman, S. E., Poutahidis, T., Tomczak, M., Rogers, A. B., Cormier, K., Plank, B., Horwitz, B. H., and Fox, J. G. (2003). CD4(+) CD25(+) Regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 162, 691-702.
20. Etzioni, R., Urban, N., Ramsey, S., McIntosh, M., Schwartz, S., Reid, B., Radich, J., Anderson, G., and Hartwell, L. (2003). The case for early detection. Nat Rev Cancer 3, 243-52.
21. Fox, J. G., Dewhirst, F. E., Shen, Z., Feng, Y., Taylor, N. S., Paster, B. J., Ericson, R. L., Lau, C. N., Correa, P., Araya, J. C., and Roa, I. (1998). Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 114, 755-63.
22. Fox, J. G., Dewhirst, F. E., Tully, J. G., Paster, B. J., Yan, L., Taylor, N. S., Collins, M. J., Jr., Gorelick, P. L., and Ward, J. M. (1994). Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol 32, 1238-45.
23. Fox, J. G., Drolet, R., Higgins, R., Messier, S., Yan, L., Coleman, B. E., Paster, B. J., and Dewhirst, F. E. (1996a). Helicobacter canis isolated from a dog liver with multifocal necrotizing hepatitis. J Clin Microbiol 34, 2479-82.
24. Fox, J. G., Li, X., Yan, L., Cahill, R. J., Hurley, R., Lewis, R., and Murphy, J. C. (1996b). Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis. Infect Immun 64, 1548-58.
25. Fox, J. G., Rogers, A. B., Whary, M. T., Ge, Z., Taylor, N. S., Xu, S., Horwitz, B. H., and Erdman, S. E. (2004). Gastroenteritis in NF-κB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect Immun 72, 1116-25.
26. Fox, J. G., Wang, T. C., Rogers, A. B., Poutahidis, T., Ge, Z., Taylor, N., Dangler, C. A., Israel, D. A., Krishna, U., Gaus, K., and Peek, R. M., Jr. (2003). Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology 124, 1879-90.
27. Fraser, D. J., Zumsteg, A., and Meyer, U. A. (2003). Nuclear receptors constitutive androstane receptor and pregnane X receptor activate a drug-responsive enhancer of the murine 5-aminolevulinic acid synthase gene. J Biol Chem 278, 39392-401.
28. Frasor, J., Danes, J. M., Komm, B., Chang, K. C., Lyttle, C. R., and Katzenellenbogen, B. S. (2003). Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144, 4562-74.
29. Furutani, M., Arii, S., Mizumoto, M., Kato, M., and Imamura, M. (1998). Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. Cancer Lett 122, 209-14.
30. Gabay, C., and Kushner, I. (1999). Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340, 448-54.
31. Graveel, C. R., Jatkoe, T., Madore, S. J., Holt, A. L., and Farnham, P. J. (2001). Expression profiling and identification of novel genes in hepatocellular carcinomas. Oncogene 20, 2704-12.
32. Hailey, J. R., Haseman, J. K., Bucher, J. R., Radovsky, A. E., Malarkey, D. E., Miller, R. T.,Nyska, A., and Maronpot, R. R. (1998). Impact of Helicobacter hepaticus infection in B6C3F1 mice from twelve National Toxicology Program two-year carcinogenesis studies. Toxicol Pathol 26, 602-11.
33. Hatanaka, E., Pereira Ribeiro, F., and Campa, A. (2003). The acute phase protein serum amyloid A primes neutrophils. FEMS Immunol Med Microbiol 38, 81-4.
34. Hinds, P. W., Dowdy, S. F., Eaton, E. N., Arnold, A., and Weinberg, R. A. (1994). Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91, 709-13.
35. Hinds, P. W., and Weinberg, R. A. (1994). Tumor suppressor genes. Curr Opin Genet Dev 4, 135-41.
36. Ihrig, M., Schrenzel, M. D., and Fox, J. G. (1999). Differential susceptibility to hepatic inflammation and proliferation in AXB recombinant inbred mice chronically infected with Helicobacter hepaticus. Am J Pathol 155, 571-82.
37. Iizuka, N., Oka, M., Yamada-Okabe, H., Hamada, K., Nakayama, H., Mori, N., Tamesa, T., Okada, T., Takemoto, N., Matoba, K., Takashima, M., Sakamoto, K., Tangoku, A., Miyamoto, T., Uchimura, S., and Hamamoto, Y. (2004). Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray. Int J Oncol 24, 565-74.
38. Jia, S. H., Li, Y., Parodo, J., Kapus, A., Fan, L., Rotstein, O. D., and Marshall, J. C. (2004). Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 113, 1318-27.
39. Jung, D., Hagenbuch, B., Fried. M., Meier, P. J., and Kullak-Ublick, G. A. (2004). Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene. Am J Physiol Gastrointest Liver Physiol 286, G752-61.
40. Kaplan, R., Luettich, K., Heguy, A., Hackett, N. R., Harvey, B. G., and Crystal, R. G. (2003). Monoallelic up-regulation of the imprinted H19 gene in airway epithelium of phenotypically normal cigarette smokers. Cancer Res 63, 1475-82.
41. Kapranov, P., Cawley, S. E., Drenkow, J., Bekiranov, S., Strausberg, R. L., Fodor, S. P., and Gingeras, T. R. (2002). Large-scale transcriptional activity in chromosomes 21 and 22. Science 296, 916-9.
42. Katoh, M. (2003). Trefoil factors and human gastric cancer (Review). Int J Mol Med 12, 3-9.
43. Kersten, S., Mandard, S., Escher, P., Gonzalez, F. J., Tafuri, S., Desvergne, B., and Wahli, W. (2001). The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism. FASEB J 15, 1971-8.
44. Keum, E., Kim, Y., Kim, J., Kwon, S., Lim, Y., Man, I., and Oh, E. S. (2004). Syndecan-4 regulates localization, activity and stability of protein kinase C-alpha. Biochem J 378, 1007-14.
45. Khan, Z. E., Wang, T. C., Cui, G., Chi, A. L., and Dimaline, R. (2003). Transcriptional regulation of the human trefoil factor, TFF1, by gastrin. Gastroenterology 125, 510-21.
46. Kimura, Y., Leung, P. S., Kenny, T. P., Van De Water, J., Nishioka, M., Giraud, A. S., Neuberger, J., Benson, G., Kaul, R., Ansari, A. A., Coppel, R. L., and Gershwin, M. E. (2002). Differential expression of intestinal trefoil factor in biliary epithelial cells of primary biliary cirrhosis. Hepatology 36, 1227-35.
47. Kuper, H., Mantzoros, C., Lagiou, P., Tzonou, A., Tamimi, R., Mucci, L., Benetou, V., Spanos, E., Stuver, S. O., and Trichopoulos, D. (2001). Estrogens, testosterone and sex hormone binding globulin in relation to liver cancer in men. Oncology 60, 355-60.
48. Lara-Tejero, M., and Galan, J. E. (2000). A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 290, 354-7.
49. LeRoith, D., Karas, M., Yakar, S., Qu, B. H., Wu, Y., and Blakesley, V. A. (1999). The role of the insulin-like growth factors in cancer. Isr Med Assoc J 1, 25-30.
50. Lepreux, S., Bioulac-Sage, P., Gabbiani, G., Sapin, V., Housset, C., Rosenbaum, J., Balabaud, C., and Desmouliere, A. (2004). Cellular retinol-binding protein-1 expression in normal and fibrotic/cirrhotic human liver: different patterns of expression in hepatic stellate cells and (myo)fibroblast subpopulations. J Hepatol 40, 774-80.
51. Leu, J. I., Crissey, M. A., and Taub, R. (2003). Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. J Clin Invest 111, 129-39.
52. Leung, W. K., Yu, J., Chan, F. K., To, K. F., Chan, M. W., Ebert, M. P., Ng, E. K., Chung, S. C., Malfertheiner, P., and Sung, J. J. (2002). Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. J Pathol 197, 582-8.
53. Li, C., and Hung Wong, W. (2001a). Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol 2, RESEARCH0032.
54. Li, C., and Wong, W. H. (2001b). Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98, 31-6.
55. Liu, Q., and Nilsen-Hamilton, M. (1995). Identification of a new acute phase protein. J Biol Chem 270, 22565-70.
56. Matsui, T., Kinoshita, T., Morikawa, Y., Tohya, K., Katsuki, M., Ito, Y., Kamiya, A., and Miyajima, A. (2002). K-Ras mediates cytokine-induced formation of E-cadherin-based adherens junctions during liver development. EMBO J 21, 1021-30.
57. McSweeney, L. A., and Dreyfus, L. A. (2004). Nuclear localization of the Escherichia colt cytolethal distending toxin CdtB subunit. Cell Microbiol 6, 447-58.
58. Meyer, K., Lee, J. S., Dyck, P. A., Cao, W. Q., Rao, M. S., Thorgeirsson, S. S., and Reddy, J. K. (2003). Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen. Carcinogenesis 24, 975-84.
59. Mootha, V. K., Bunkenborg, J., Olsen, J. V., Hjerrild, M., Wisniewski, J. R., Stahl, E., Bolouri, M. S., Ray, H. N., Sihag, S., Kamal, M., Patterson, N., Lander, E. S., and Mann, M. (2003a). Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 115, 629-40.
60. Mootha, V. K., Lindgren, C. M., Eriksson, K. F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstrale, M., Laurila, E., Houstis, N., Daly, M. J., Patterson, N., Mesirov, J. P., Golub, T. R., Tamayo, P., Spiegelman, B., Lander, E. S., Hirschhorn, J. N., Altshuler, D., and Groop, L. C. (2003b). PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34, 267-73.
61. Myles, M. H., Livingston, R. S., Livingston, B. A., Criley, J. M., and Franklin, C. L. (2003). Analysis of gene expression in ceca of Helicobacter hepaticus-infected A/JCr mice before and after development of typhlitis. Infect Immun 71, 3885-93.
62. Nielsen, B. S., Borregaard, N., Bundgaard, J. R., Timshel, S., Sehested, M., and Kjeldsen, L. (1996). Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 38, 414-20.
63. Nilsen-Hamilton, M., Hamilton, R. T., and Adams, G. A. (1982). Rapid selective stimulation by growth factors of the incorporation by BALB/C 3T3 cells of [35S]methionine into a glycoprotein and five superinducible proteins. Biochem Biophys Res Commun 108, 158-66.
64. Nilsson, H. O., Mulchandani, R., Tranberg, K. G., and Wadstrom, T. (2001). Helicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma. Gastroenterology 120, 323-4.
65. Nowak, A., Findlay, M., Culjak, G., and Stockler, M. (2004). Tamoxifen for hepatocellular carcinoma. Cochrane Database Syst Rev, CD001024.
66. Nyska, A., Maronpot, R. R., Eldridge, S. R., Haseman, J. K., and Hailey, J. R. (1997). Alteration in cell kinetics in control B6C3F1 mice infected with Helicobacter hepaticus. Toxicol Pathol 25, 591-6.
67. Ohara, M., Hayashi, T., Kusunoki, Y., Miyauchi, M., Takata, T., and Sugai, M. (2004). Caspase-2 and caspase-7 are involved in cytolethal distending toxin-induced apoptosis in Jurkat and MOLT-4 T-cell lines. Infect Immun 72, 871-9.
68. Palmer, H. G., Sanchez-Carbayo, M., Ordonez-Moran, P., Larriba, M. J., Cordon-Cardo, C., and Munoz, A. (2003). Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res 63, 7799-806.
69. Parker, M. A., Deane, N. G., Thompson, E. A., Whitehead, R. H., Mithani, S. K., Washington, M. K., Datta, P. K., Dixon, D. A., and Beauchamp, R. D. (2003). Over-expression of cyclin D1 regulates Cdk4 protein synthesis. Cell Prolif 36, 347-60.
70. Patsouris, D., Mandard, S., Voshol, P. J., Escher, P., Tan, N. S., Havekes, L. M., Koenig, W., Marz, W., Tafuri, S., Wahli, W., Muller, M., and Kersten, S. (2004). PPARalpha governs glycerol metabolism. J Clin Invest 114, 94-103.
71. Pawson, T., and Nash, P. (2003). Assembly of cell regulatory systems through protein interaction domains. Science 300, 445-52.
72. Payne, A. H., Abbaszade, I. G., Ciarke, T. R., Bain, P. A., and Park, C. H. (1997). The multiple murine 3 beta-hydroxysteroid dehydrogenase isoforms: structure, function, and tissue- and developmentally specific expression. Steroids 62, 169-75.
73. Ponzetto, A., Pellicano, R., Leone, N., Cutufia, M. A., Turrini, F., Grigioni, W. F., D'Errico, A., Mortimer, P., Rizzetto, M., and Silengo, L. (2000). Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? Med Hypotheses 54, 275-7.
74. Ramljak, D., Jones, A. B., Diwan, B. A., Perantoni, A. O., Hochadel, J. F., and Anderson, L. M. (1998). Epidermal growth factor and transforming growth factor-alpha-associated overexpression of cyclin D1, Cdk4, and c-Myc during hepatocarcinogenesis in Helicobacter hepaticus-infected A/JCr mice. Cancer Res 58, 3590-7.
75. Ribeiro, F P., Furlaneto, C. J., Hatanaka, E., Ribeiro, W. B., Souza, G. M., Cassatella, M. A., and Campa, A. (2003). mRNA expression and release of interleukin-8 induced by serum amyloid A in neutrophils and monocytes. Mediators Inflamm 12, 173-8.
76. Rivera-Rivera, I., Kim, J., and Kemper, B. (2003). Transcriptional analysis in vivo of the hepatic genes, Cyp2b9 and Cyp2b10, by intravenous administration of plasmid DNA in mice. Biochim Biophys Acta 1619, 254-62.
77. Rodrigues, S., Attoub, S., Nguyen, Q. D., Bruyneel, E., Rodrigue, C. M., Westley, B. R., May, F. E., Thim, L., Mareel, M., Emami, S., and Gespach, C. (2003). Selective abrogation of the proinvasive activity of the trefoil peptides pS2 and spasmolytic polypeptide by disruption of the EGF receptor signaling pathways in kidney and colonie cancer cells. Oncogene 22, 4488-97.
78. Rogers, A. B., and Fox, J. G. (2004). Inflammation and Cancer I. Rodent models of infectious gastrointestinal and liver cancer. Am J Physiol Gastrointest Liver Physiol 286, G361-6.
79. Scharf, J. G., Dombrowski, F., and Ramadori, G. (2001). The IGF axis and hepatocarcinogenesis. Mol Pathol 54, 138-44.
80. Selvamurugan, N., Kwok, S., and Partridge, N. C. (2004). Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells. J Biol Chem 279, 27764-73.
81. Sipowicz, M. A., Chomarat, P., Diwan, B. A., Anver, M. A., Awasthi, Y. C., Ward, J. M., Rice, J. M., Kasprzak, K. S., Wild, C. P., and Anderson, L. M. (1997a). Increased oxidative DNA damage and hepatocyte overexpression of specific cytochrome P450 isoforms in hepatitis of mice infected with Helicobacter hepaticus. Am J Pathol 151, 933-41.
82. Sipowicz, M. A., Weghorst, C. M., Shiao, Y. H., Buzard, G. S., Calvert, R. J., Anver, M. R., Anderson, L. M., and Rice, J. M. (1997b). Lack of p53 and ras mutations in Helicobacter hepaticus-induced liver tumors in A/JCr mice. Carcinogenesis 18, 233-6.
83. Song, X., Tao, Y. G., Deng, X. Y., Jin, X., Tan, Y. N., Tang, M., Wu, Q., Lee, L. M., and Cao, Y. (2004). Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1. Cell Signal 16, 1153-62.
84. Tanaka, K., Sakai, H., Hashizume, M., and Hirohata, T. (2000). Serum testosterone:estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients. Cancer Res 60, 5106-10.
85. Taylor, N. S., Ge, Z., Shen, Z., Dewhirst, F. E., and Fox, J. G. (2003). Cytolethal distending toxin: a potential virulence factor for Helicobacter cinaedi. J Infect Dis 188, 1892-7.
86. Thirunavukkarasu, C., and Sakthisekaran, D. (2003). Effect of dietary selenite on N-nitrosodiethylamine-induced and phenobarbital promoted multistage hepatocarcinogenesis in rat: reflection in some minerals. Biomed Pharmacother 57, 416-21.
87. Tomczak, M. F., Erdman, S. E., Poutahidis, T., Rogers, A. B., Holcombe, H., Plank, B., Fox, J. G., and Horwitz, B. H. (2003). NF-kappaB is required within the innate immune system to inhibit microflora-induced colitis and expression of IL-12 p40. J Immunol 171, 1484-92.
88. Tong, Z., Wu, X., and Kehrer, J. P. (2003). Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886. Biochem J 372, 203-10.
89. Vernucci, M., Cerrato, F., Besnard, N., Casola, S., Pedone, P. V., Bruni, C. B., and Riccio, A. (2000). The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis. Oncogene 19, 6376-85.
90. Ward, J. M., Fox, J. G., Anver, M. R., Haines, D. C., George, C. V., Collins, M. J., Jr., Gorelick, P. L., Nagashima, K., Gonda, M. A., Gilden, R. V., and et al. (1994). Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 86, 1222-7.
91. Wong, J. S., and Gill, S. S. (2002). Gene expression changes induced in mouse liver by di(2-ethylhexyl) phthalate. Toxicol Appl Pharmacol 185, 180-96.
92. Wong, J. S., Ye, X., Muhlenkamp, C. R., and Gill, S. S. (2002). Effect of a peroxisome proliferator on 3 beta-hydroxysteroid dehydrogenase. Biochem Biophys Res Commun 293, 549-53.
93. Xu, S., and Venge, P. (2000). Lipocalins as biochemical markers of disease. Biochim Biophys Acta 1482, 298-307.
94. Yakar, S., Liu, J. L., Stannard, B., Butler, A., Accili, D., Sauer, B., and LeRoith, D. (1999). Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96, 7324-9.
95. Yamamoto, Y., Nishikawa, Y., Tokairin, T., Omori, Y., and Enomoto, K. (2004). Increased expression of H19 non-coding mRNA follows hepatocyte proliferation in the rat and mouse. J Hepatol 40, 808-14.
96. Yang, J., Mori, K., Li, J. Y., and Barasch, J. (2003). Iron, lipocalin, and kidney epithelia. Am J Physiol Renal Physiol 285, F9-18.
97. Yoshinari, K., Kobayashi, K., Moore, R., Kawamoto, T., and Negishi, M. (2003). Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital. FEBS Lett 548, 17-20.
98. Young, V. B., Knox, K. A., Pratt, J. S., Cortez, J. S., Mansfield, L. S., Rogers, A. B., Fox, J. G., and Schauer, D. B. (2004). In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants. Infect Immun 72, 2521-7.
99. Young, V. B., Knox, K. A., and Schauer, D. B. (2000). Cytolethal distending toxin sequence and activity in the enterohepatic pathogen Helicobacter hepaticus. Infect Immun 68, 184-91.